Objective
Methods
Results
Conclusions
CTSNet classification
Abbreviations and Acronyms:
CrI (credible interval), ICU (intensive care unit), PLOS (postoperative length of stay), STSCHSD (Society of Thoracic Surgeons Congenital Heart Surgery Database), STS-EACTS (Society of Thoracic Surgeons-European Association for Cardiothoracic Surgery)
- •to develop a morbidity metric based on both the occurrence of complications that have a significant and durable impact on patient health and utilization of health care resources;
- •to estimate the average amount of patient morbidity by procedure type;
- •to convert these procedure-specific morbidity estimates into a scale ranging from 0.1 to 5.0 (range was chosen for consistency with the STS-EACTS Mortality Score2); and
- •to group procedures with similar estimated morbidity risk into 5 relatively homogeneous categories that were designed to minimize within-category variation and to serve as a stratification variable that can be used to adjust for case mix when analyzing outcomes and comparing institutions.
Materials and Methods
Study Population
Classification of Multiple-Procedure Operations
End Points
Procedure name (STS code) | No. | Morbidity | PLOS (d) | Any major complications | |||
---|---|---|---|---|---|---|---|
Category | Score | Average (IQR) | Model-based estimate (95% CrI) | Raw (95% CI) | Model (95% CrI) | ||
ASD repair, patch (30) | 2469 | 1 | 0.1 | 4.1 (3.0-4.0) | 4.1 (3.8-4.4) | 0.8% (0.5-1.2) | 1.0% (0.7-1.4) |
ICD (AICD) implantation (1470) | 358 | 1 | 0.1 | 3.2 (1.0-3.0) | 3.2 (2.6-3.9) | 1.7% (0.8-3.6) | 2.1% (1.1-3.5) |
ICD (AICD) procedure (1480) | 156 | 1 | 0.1 | 2.8 (1.0-3.0) | 2.9 (2.1-3.7) | 2.6% (1.0-6.4) | 2.9% (1.3-5.1) |
ASD repair, patch + PAPVC repair (3100) | 319 | 1 | 0.1 | 3.7 (3.0-4.0) | 3.7 (3.4-3.9) | 1.6% (0.7-3.6) | 2.1% (1.1-3.7) |
Pacemaker procedure (1460) | 1413 | 1 | 0.2 | 3.9 (0.0-3.0) | 3.9 (3.1-4.7) | 2.0% (1.4-2.8) | 2.1% (1.5-2.9) |
ASD repair, primary closure (20) | 947 | 1 | 0.2 | 5.0 (3.0-4.0) | 5.0 (4.4-5.6) | 1.3% (0.7-2.2) | 1.6% (1.0-2.4) |
AVC (AVSD) repair, partial (incomplete) (PAVSD) (190) | 772 | 1 | 0.3 | 5.1 (3.0-5.0) | 5.1 (4.6-5.7) | 2.1% (1.3-3.3) | 2.3% (1.5-3.3) |
DCRV repair (570) | 352 | 1 | 0.3 | 5.1 (3.0-5.0) | 5.1 (4.6-5.6) | 2.8% (1.6-5.1) | 3.1% (1.7-4.9) |
PAPVC repair (260) | 370 | 1 | 0.4 | 5.4 (3.0-5.0) | 5.4 (4.2-6.7) | 2.4% (1.3-4.6) | 2.8% (1.6-4.5) |
Vascular ring repair (1360) | 1006 | 1 | 0.4 | 6.3 (2.0-4.0) | 6.3 (5.4-7.2) | 1.5% (0.9-2.4) | 1.8% (1.2-2.6) |
Pacemaker implantation, permanent (1450) | 1147 | 1 | 0.4 | 5.7 (1.0-4.0) | 5.7 (4.8-6.6) | 2.4% (1.7-3.5) | 2.6% (1.8-3.6) |
Aneurysm, pulmonary artery, repair (1740) | 16 | 1 | 0.4 | 4.7 (3.0-5.0) | 4.9 (2.6-7.3) | 0.0% (0.0-19.4) | 3.6% (1.2-7.9) |
Coronary artery fistula ligation (1290) | 29 | 1 | 0.4 | 4.9 (3.0-6.0) | 5.0 (3.6-6.3) | 3.4% (0.2-17.2) | 3.9% (1.6-8.3) |
Aortic stenosis, subvalvar, repair (780) | 1573 | 1 | 0.4 | 4.7 (3.0-5.0) | 4.7 (4.5-5.0) | 4.3% (3.4-5.4) | 4.2% (3.3-5.2) |
Valve replacement, pulmonic (600) | 1097 | 1 | 0.4 | 5.3 (3.0-6.0) | 5.3 (5.0-5.6) | 3.6% (2.7-4.9) | 3.6% (2.7-4.8) |
Coarctation repair, interposition graft (1250) | 102 | 1 | 0.4 | 6.1 (4.0-6.8) | 6.1 (5.0-7.3) | 2.0% (0.5-6.9) | 3.2% (1.4-5.9) |
Valvuloplasty, pulmonic (590) | 230 | 1 | 0.5 | 6.9 (3.0-5.8) | 6.9 (5.2-8.5) | 1.7% (0.7-4.4) | 2.7% (1.3-4.6) |
Atrial baffle procedure (non-Mustard, non-Senning) (310) | 23 | 1 | 0.5 | 6.3 (3.0-7.5) | 6.4 (4.8-8.0) | 0.0% (0.0-14.3) | 3.8% (1.3-8.1) |
VSD repair, primary closure (100) | 448 | 1 | 0.5 | 6.0 (3.0-5.0) | 6.0 (5.2-6.8) | 4.7% (3.1-7.1) | 4.6% (3.0-6.6) |
Valvuloplasty, aortic (660) | 667 | 1 | 0.6 | 6.4 (3.0-6.0) | 6.4 (5.6-7.2) | 4.2% (2.9-6.0) | 4.2% (2.9-5.8) |
Conduit placement, LV to PA (620) | 19 | 1 | 0.6 | 6.8 (4.0-9.0) | 6.8 (5.0-8.7) | 0.0% (0.0-16.8) | 4.0% (1.4-8.8) |
Aortic root replacement, valve sparing (735) | 102 | 1 | 0.6 | 6.0 (4.0-7.0) | 6.0 (5.4-6.6) | 5.9% (2.7-12.2) | 5.1% (2.6-8.9) |
VSD repair, patch (110) | 4868 | 1 | 0.6 | 7.7 (3.0-7.0) | 7.7 (7.3-8.0) | 3.3% (2.9-3.9) | 3.4% (2.9-3.9) |
AVC (AVSD) repair, intermediate (transitional) (180) | 344 | 1 | 0.6 | 6.9 (3.0-6.0) | 7.0 (5.8-8.1) | 4.7% (2.9-7.4) | 4.7% (2.9-6.9) |
Coarctation repair, end to end (1210) | 1214 | 1 | 0.6 | 9.0 (3.0-7.0) | 8.9 (7.9-9.9) | 2.2% (1.5-3.2) | 2.5% (1.7-3.4) |
TOF repair, ventriculotomy, nontransannular patch (360) | 693 | 1 | 0.7 | 7.3 (4.0-7.0) | 7.3 (6.7-7.8) | 4.8% (3.4-6.6) | 4.8% (3.3-6.4) |
Conduit reoperation (580) | 1244 | 1 | 0.7 | 7.2 (4.0-6.0) | 7.2 (6.6-7.9) | 5.4% (4.3-6.8) | 5.3% (4.2-6.6) |
PFO, primary closure (10) | 129 | 1 | 0.7 | 7.4 (4.0-7.0) | 7.5 (5.9-9.1) | 5.4% (2.7-10.8) | 5.2% (2.7-8.7) |
TOF repair, no ventriculotomy (350) | 768 | 1 | 0.7 | 8.3 (5.0-8.0) | 8.3 (7.7-9.0) | 4.2% (3.0-5.8) | 4.3% (3.0-5.7) |
Ross procedure (740) | 480 | 1 | 0.7 | 5.9 (4.0-6.0) | 5.9 (5.5-6.3) | 7.9% (5.8-10.7) | 7.4% (5.4-9.8) |
PA, reconstruction (plasty), main (trunk) (530) | 175 | 1 | 0.8 | 7.1 (3.0-6.0) | 7.3 (5.7-8.9) | 6.3% (3.5-10.9) | 5.8% (3.3-9.2) |
Atrial fenestration closure (85) | 19 | 1 | 0.8 | 7.6 (4.0-10.0) | 7.8 (5.2-10.5) | 5.3% (0.3-24.6) | 5.3% (2.0-11.2) |
ASD, common atrium (single atrium), septation (50) | 41 | 1 | 0.8 | 8.5 (3.0-5.0) | 8.7 (4.0-13.5) | 2.4% (0.1-12.6) | 4.6% (1.7-9.5) |
Valvuloplasty, mitral (830) | 1365 | 1 | 0.8 | 8.7 (4.0-7.0) | 8.7 (8.0-9.4) | 5.0% (3.9-6.3) | 5.0% (4.0-6.2) |
Cor triatriatum repair (290) | 127 | 1 | 0.8 | 9.6 (4.0-7.0) | 9.5 (6.9-12.2) | 3.1% (1.2-7.8) | 4.3% (2.1-7.4) |
PA debanding (1650) | 75 | 1 | 0.8 | 8.5 (4.0-9.5) | 8.5 (6.6-10.4) | 5.3% (2.1-12.9) | 5.4% (2.5-9.6) |
AVR, bioprosthetic (690) | 90 | 2 | 0.9 | 6.6 (3.2-6.0) | 6.8 (5.4-8.3) | 11.1% (6.1-19.3) | 8.3% (4.4-13.8) |
Aortic stenosis, supravalvar, repair (790) | 268 | 2 | 0.9 | 7.7 (4.0-7.0) | 7.8 (6.5-9.1) | 7.8% (5.2-11.7) | 7.3% (4.7-10.4) |
Coarctation repair, end to end, extended (1220) | 1773 | 2 | 0.9 | 11.6 (4.0-10.0) | 11.5 (10.6-12.5) | 2.9% (2.2-3.8) | 3.1% (2.3-3.9) |
Sinus of Valsalva, aneurysm repair (810) | 33 | 2 | 0.9 | 7.0 (4.0-9.0) | 7.3 (5.5-9.2) | 15.2% (6.7-30.9) | 8.4% (3.6-15.7) |
Aortopexy (1365) | 50 | 2 | 1 | 20.7 (2.0-8.5) | 11.1 (2.6-19.3) | 0.0% (0.0-7.1) | 4.4% (1.4-9.3) |
Valvuloplasty, tricuspid (460) | 927 | 2 | 1 | 9.4 (4.0-8.0) | 9.4 (8.2-10.7) | 6.4% (5.0-8.1) | 6.3% (4.9-7.9) |
Aortic root replacement, bioprosthetic (715) | 47 | 2 | 1 | 6.8 (4.0-7.0) | 7.1 (5.6-8.6) | 14.9% (7.4-27.7) | 9.1% (4.2-16.0) |
Conduit placement, other (1772) | 38 | 2 | 1 | 9.5 (4.0-7.0) | 9.9 (5.3-14.4) | 5.3% (1.5-17.3) | 6.0% (2.4-11.8) |
Pericardiectomy (930) | 63 | 2 | 1 | 11.8 (4.0-10.5) | 11.1 (7.6-14.8) | 1.6% (0.1-8.5) | 4.6% (1.9-8.8) |
Bidirectional cavopulmonary anastomosis (bidirectional Glenn) (1670) | 2042 | 2 | 1 | 9.7 (4.0-9.0) | 9.7 (9.1-10.3) | 6.5% (5.5-7.6) | 6.4% (5.4-7.6) |
RVOT procedure (510) | 1426 | 2 | 1 | 9.8 (4.0-8.0) | 9.8 (8.8-10.9) | 6.6% (5.4-8.0) | 6.5% (5.4-7.8) |
Fontan, TCPC, lateral tunnel, nonfenestrated (980) | 140 | 2 | 1 | 10.0 (4.8-12.0) | 10.1 (8.6-11.4) | 6.4% (3.4-11.8) | 6.4% (3.5-10.1) |
1 1/2 ventricular repair (520) | 20 | 2 | 1 | 8.7 (4.0-7.0) | 9.5 (5.2-14.0) | 10.0% (2.8-30.1) | 7.1% (2.6-15.1) |
Anomalous systemic venous connection repair (330) | 200 | 2 | 1.1 | 10.1 (4.0-10.0) | 10.2 (8.2-12.2) | 6.5% (3.8-10.8) | 6.5% (3.8-9.8) |
Mitral stenosis, supravalvar mitral ring repair (840) | 76 | 2 | 1.1 | 10.0 (4.0-8.0) | 10.4 (5.8-14.7) | 6.6% (2.8-14.5) | 6.6% (3.0-11.6) |
PDA closure, surgical (1330) | 1507 | 2 | 1.1 | 14.1 (2.0-9.0) | 13.8 (12.3-15.3) | 2.6% (1.9-3.5) | 2.9% (2.2-3.8) |
Hemi-Fontan (1700) | 245 | 2 | 1.1 | 11.2 (6.0-12.0) | 11.2 (9.7-12.8) | 5.7% (3.4-9.4) | 6.0% (3.7-8.8) |
Aortic aneurysm repair (1380) | 264 | 2 | 1.1 | 9.3 (4.0-8.0) | 9.6 (7.7-11.5) | 8.7% (5.9-12.7) | 8.2% (5.4-11.5) |
PAPVC, scimitar, repair (270) | 64 | 2 | 1.2 | 10.2 (4.0-8.0) | 10.6 (6.9-14.3) | 7.8% (3.4-17.0) | 7.3% (3.5-12.9) |
Bilateral bidirectional cavopulmonary anastomosis (bilateral bidirectional Glenn) (1690) | 360 | 2 | 1.2 | 10.9 (5.0-10.0) | 11.0 (9.6-12.5) | 7.2% (5.0-10.4) | 7.2% (4.9-9.9) |
Systemic venous stenosis repair (340) | 39 | 2 | 1.2 | 13.7 (4.5-10.0) | 12.2 (6.1-18.1) | 2.6% (0.1-13.2) | 5.9% (2.2-11.9) |
Fontan, TCPC, lateral tunnel, fenestrated (970) | 822 | 2 | 1.2 | 11.4 (7.0-12.0) | 11.4 (10.7-12.1) | 7.1% (5.5-9.0) | 7.1% (5.5-8.8) |
AVR, homograft (700) | 18 | 2 | 1.2 | 7.8 (4.0-6.0) | 9.0 (5.5-12.8) | 22.2% (9.0-45.2) | 9.9% (4.0-19.4) |
Aortopulmonary window repair (210) | 80 | 2 | 1.2 | 12.5 (5.0-14.0) | 12.3 (9.5-15.1) | 5.0% (2.0-12.2) | 6.2% (3.0-10.7) |
TOF repair, ventriculotomy, transannular patch (370) | 1721 | 2 | 1.2 | 11.1 (5.0-11.0) | 11.1 (10.3-11.9) | 7.7% (6.6-9.1) | 7.7% (6.6-8.9) |
AVR, mechanical (680) | 214 | 2 | 1.2 | 9.2 (5.0-8.0) | 9.4 (7.9-10.8) | 10.7% (7.3-15.6) | 9.7% (6.4-13.9) |
Glenn (unidirectional cavopulmonary anastomosis) (unidirectional Glenn) (1680) | 23 | 2 | 1.2 | 12.3 (5.0-8.0) | 12.0 (6.4-17.3) | 4.3% (0.2-21.0) | 6.9% (2.4-14.2) |
ASD partial closure (70) | 14 | 2 | 1.3 | 22.2 (6.2-20.0) | 12.6 (2.7-22.1) | 0.0% (0.0-21.5) | 6.9% (1.8-17.3) |
PA, reconstruction (plasty), branch, peripheral (at or beyond the hilar bifurcation) (550) | 163 | 2 | 1.3 | 11.0 (4.0-11.5) | 11.2 (8.8-13.6) | 9.2% (5.7-14.6) | 8.6% (5.2-12.6) |
PA, reconstruction (plasty), branch, central (within the hilar bifurcation) (540) | 694 | 2 | 1.3 | 11.7 (4.0-11.0) | 11.7 (10.5-13.1) | 8.4% (6.5-10.7) | 8.3% (6.3-10.4) |
Conduit placement, RV to PA (610) | 703 | 2 | 1.3 | 11.9 (4.0-10.0) | 11.9 (10.4-13.5) | 8.1% (6.3-10.4) | 8.1% (6.3-10.1) |
AVC (AVSD) repair, complete AVSD (170) | 2332 | 2 | 1.3 | 12.8 (5.0-13.0) | 12.8 (12.1-13.6) | 7.0% (6.1-8.1) | 7.1% (6.1-8.1) |
Partial left ventriculectomy (LV volume reduction surgery) (Batista) (910) | 33 | 2 | 1.3 | 15.7 (6.0-21.0) | 14.0 (8.9-18.7) | 0.0% (0.0-10.4) | 5.9% (2.2-12.1) |
LV to aorta tunnel repair (820) | 17 | 2 | 1.3 | 12.5 (6.0-20.0) | 12.5 (8.4-16.8) | 5.9% (0.3-27.0) | 7.7% (2.8-15.8) |
Coarctation repair, subclavian flap (1230) | 179 | 2 | 1.4 | 13.7 (5.0-12.0) | 13.5 (11.1-15.9) | 6.1% (3.5-10.7) | 6.7% (4.0-10.1) |
Ventricular septal fenestration (150) | 24 | 2 | 1.4 | 17.8 (4.8-9.2) | 13.2 (4.5-21.5) | 4.2% (0.2-20.2) | 7.4% (2.4-15.8) |
Glenn + PA reconstruction (3300) | 458 | 2 | 1.4 | 11.6 (5.0-11.0) | 11.7 (10.1-13.2) | 9.8% (7.4-12.9) | 9.6% (7.2-12.3) |
VSD, multiple, repair (130) | 142 | 2 | 1.5 | 12.5 (5.0-11.0) | 12.7 (9.2-16.0) | 9.2% (5.4-15.0) | 8.8% (5.2-13.4) |
Shunt, ligation, and takedown (1630) | 58 | 2 | 1.5 | 11.6 (4.0-11.8) | 12.0 (8.9-15.2) | 12.1% (6.0-22.9) | 10.0% (5.1-16.9) |
Aortic root replacement, mechanical (720) | 84 | 2 | 1.5 | 9.8 (6.0-11.0) | 10.2 (8.3-12.1) | 15.5% (9.3-24.7) | 12.1% (7.0-18.7) |
Cardiac tumor resection (1760) | 226 | 2 | 1.5 | 15.4 (4.0-15.8) | 14.9 (12.2-17.8) | 6.6% (4.1-10.7) | 7.2% (4.6-10.4) |
Coronary artery bypass (1300) | 78 | 2 | 1.5 | 10.5 (4.0-8.0) | 11.8 (7.6-16.0) | 12.8% (7.1-22.0) | 10.7% (5.7-17.1) |
Aneurysm, ventricular, right, repair (1720) | 80 | 2 | 1.5 | 12.9 (4.0-10.0) | 13.1 (9.4-16.8) | 10.0% (5.2-18.5) | 9.4% (5.0-15.3) |
Coarctation repair, patch aortoplasty (1240) | 172 | 3 | 1.6 | 14.7 (4.0-14.0) | 14.4 (11.0-17.7) | 8.1% (4.9-13.2) | 8.3% (5.2-12.2) |
Pericardial drainage procedure (920) | 245 | 3 | 1.6 | 20.0 (4.0-18.0) | 17.4 (13.3-21.4) | 3.7% (1.9-6.8) | 5.2% (3.0-7.9) |
Arrhythmia surgery ventricular, surgical ablation (1500) | 40 | 3 | 1.6 | 13.6 (4.0-7.0) | 13.7 (6.2-21.4) | 10.0% (4.0-23.1) | 9.6% (3.8-17.8) |
Anomalous origin of coronary artery repair (1291) | 287 | 3 | 1.6 | 13.5 (5.0-16.0) | 13.5 (11.5-15.6) | 10.1% (7.1-14.1) | 9.9% (6.8-13.5) |
Konno procedure (750) | 134 | 3 | 1.6 | 11.5 (5.0-11.0) | 12.0 (9.2-14.7) | 13.4% (8.7-20.2) | 11.8% (7.4-17.0) |
Arrhythmia surgery atrial, surgical ablation (1490) | 259 | 3 | 1.6 | 10.4 (5.0-11.0) | 10.6 (9.2-12.0) | 14.7% (10.9-19.5) | 13.4% (9.6-17.7) |
Fontan, TCPC, external conduit, nonfenestrated (1010) | 883 | 3 | 1.6 | 13.5 (7.0-14.0) | 13.5 (12.6-14.5) | 10.4% (8.6-12.6) | 10.3% (8.4-12.4) |
Aortic root replacement, homograft (730) | 99 | 3 | 1.7 | 14.3 (4.5-10.5) | 14.2 (9.2-19.1) | 10.1% (5.6-17.6) | 9.8% (5.3-15.4) |
Atrial septal fenestration (80) | 18 | 3 | 1.7 | 12.3 (4.0-20.2) | 13.3 (8.1-18.7) | 16.7% (5.8-39.2) | 11.2% (4.3-22.0) |
Aneurysm, ventricular, left, repair (1730) | 28 | 3 | 1.7 | 12.3 (5.8-16.0) | 12.7 (9.7-15.8) | 17.9% (7.9-35.6) | 12.1% (5.5-22.1) |
Arterial switch operation (1110) | 1400 | 3 | 1.7 | 14.0 (8.0-15.0) | 14.0 (13.2-14.7) | 10.8% (9.3-12.5) | 10.7% (9.2-12.4) |
TOF repair, RV-PA conduit (380) | 336 | 3 | 1.7 | 15.8 (6.0-15.0) | 15.7 (13.3-18.0) | 8.9% (6.3-12.5) | 9.1% (6.4-12.2) |
Pulmonary artery origin from ascending aorta (hemitruncus) repair (220) | 45 | 3 | 1.7 | 15.6 (8.0-21.0) | 15.2 (11.8-18.7) | 8.9% (3.5-20.7) | 9.6% (4.5-17.1) |
Occlusion MAPCA(s) (450) | 26 | 3 | 1.7 | 24.8 (6.0-21.8) | 15.3 (6.8-24.0) | 7.7% (2.1-24.1) | 9.6% (3.5-19.4) |
Congenitally corrected TGA repair, atrial switch and Rastelli (1060) | 11 | 3 | 1.7 | 42.7 (10.5-23.0) | 14.7 (4.4-25.1) | 9.1% (0.5-37.7) | 10.3% (2.7-24.3) |
Fontan, atriopulmonary connection (950) | 37 | 3 | 1.8 | 15.2 (7.0-14.0) | 14.9 (10.0-19.8) | 10.8% (4.3-24.7) | 10.4% (4.6-18.8) |
REV (1160) | 10 | 3 | 1.8 | 21.5 (6.2-11.8) | 14.8 (4.7-24.8) | 10.0% (0.5-40.4) | 10.6% (2.9-24.8) |
Pulmonary embolectomy, acute pulmonary embolus (1802) | 10 | 3 | 1.8 | 24.9 (3.0-30.0) | 15.0 (5.1-24.9) | 10.0% (0.5-40.4) | 10.7% (2.8-24.9) |
Ligation, pulmonary artery (1790) | 12 | 3 | 1.8 | 13.7 (5.5-11.2) | 14.4 (7.0-22.1) | 16.7% (4.7-44.8) | 11.6% (3.6-24.5) |
Ebstein’s repair (465) | 117 | 3 | 1.9 | 13.8 (4.0-15.0) | 14.1 (11.2-16.9) | 13.7% (8.6-21.1) | 12.5% (7.8-18.5) |
Fontan, TCPC, external conduit, fenestrated (1000) | 902 | 3 | 1.9 | 14.9 (7.0-16.0) | 14.9 (14.0-15.9) | 12.1% (10.1-14.4) | 12.0% (10.0-14.1) |
Senning (1130) | 10 | 3 | 1.9 | 17.9 (8.2-24.8) | 15.8 (8.6-22.7) | 10.0% (0.5-40.4) | 11.2% (3.6-24.2) |
Pulmonary artery sling repair (1370) | 80 | 3 | 1.9 | 23.8 (4.0-18.2) | 17.1 (10.0-24.1) | 8.8% (4.3-17.0) | 9.8% (5.0-16.5) |
DORV, intraventricular tunnel repair (1180) | 443 | 3 | 2 | 14.8 (6.0-15.0) | 14.9 (12.8-16.9) | 13.1% (10.3-16.6) | 12.8% (10.0-15.9) |
Coarctation repair + VSD repair (1275) | 254 | 3 | 2 | 18.2 (7.0-19.0) | 17.8 (15.1-20.4) | 9.8% (6.8-14.1) | 10.2% (7.0-14.0) |
Valve replacement, mitral (850) | 526 | 3 | 2.1 | 13.9 (6.0-15.0) | 14.1 (12.6-15.6) | 16.0% (13.1-19.3) | 15.5% (12.6-18.7) |
Valve replacement, tricuspid (470) | 134 | 3 | 2.1 | 12.3 (4.0-11.0) | 13.3 (10.0-16.7) | 18.7% (13.0-26.1) | 16.4% (11.0-22.6) |
Valve replacement, truncal valve (250) | 11 | 3 | 2.1 | 17.5 (4.0-20.5) | 16.2 (8.6-23.9) | 18.2% (5.1-47.7) | 13.2% (4.5-27.5) |
Pulmonary venous stenosis repair (300) | 286 | 3 | 2.1 | 18.0 (6.0-21.0) | 17.7 (15.1-20.2) | 11.5% (8.3-15.8) | 11.7% (8.3-15.4) |
VSD creation/enlargement (140) | 84 | 3 | 2.1 | 12.8 (5.0-13.0) | 13.6 (10.4-16.8) | 20.2% (13.0-30.0) | 16.7% (10.4-24.3) |
Fontan revision or conversion (re-do Fontan) (1025) | 107 | 3 | 2.2 | 14.0 (7.0-16.5) | 14.4 (12.0-16.7) | 18.7% (12.4-27.1) | 16.4% (10.8-23.3) |
Aortic arch repair (1280) | 785 | 3 | 2.2 | 18.4 (6.0-20.0) | 18.2 (16.5-20.1) | 12.1% (10.0-14.6) | 12.2% (10.0-14.6) |
Pulmonary atresia VSD (including TOF, PA) repair (420) | 218 | 3 | 2.2 | 17.6 (7.0-15.0) | 17.4 (14.3-20.5) | 13.8% (9.8-19.0) | 13.5% (9.6-17.9) |
Valvuloplasty, truncal valve (240) | 14 | 3 | 2.3 | 16.6 (4.2-18.8) | 16.6 (9.4-23.9) | 21.4% (7.6-47.6) | 14.8% (5.4-29.0) |
TOF - AVC (AVSD) repair (390) | 121 | 3 | 2.3 | 17.7 (7.0-19.0) | 17.4 (13.8-20.7) | 14.9% (9.6-22.3) | 14.3% (9.2-20.2) |
Ross–Konno procedure (760) | 166 | 3 | 2.3 | 16.3 (6.0-14.8) | 16.5 (13.5-19.6) | 16.9% (11.9-23.3) | 15.9% (11.1-21.4) |
PA banding (1640) | 973 | 4 | 2.5 | 25.1 (6.0-29.0) | 24.2 (22.1-26.4) | 8.2% (6.7-10.1) | 8.6% (7.0-10.4) |
Congenitally corrected TGA repair, atrial switch, and ASO (double switch) (1050) | 27 | 4 | 2.5 | 17.0 (8.0-23.0) | 17.2 (12.3-22.1) | 22.2% (10.6-40.8) | 16.8% (8.1-28.7) |
Shunt, systemic to pulmonary, modified Blalock–Taussig shunt (1590) | 1966 | 4 | 2.5 | 21.6 (7.0-23.0) | 21.5 (20.1-22.8) | 12.4% (11.0-13.9) | 12.4% (11.0-13.9) |
Shunt, systemic to pulmonary, central (from aorta or to main pulmonary artery) (1600) | 482 | 4 | 2.5 | 24.0 (7.0-27.0) | 22.8 (19.9-25.6) | 10.8% (8.3-13.9) | 11.3% (8.6-14.2) |
ASO and VSD repair (1120) | 670 | 4 | 2.6 | 17.9 (8.0-19.8) | 18.0 (16.4-19.6) | 17.8% (15.1-20.8) | 17.5% (14.8-20.5) |
Rastelli (1150) | 308 | 4 | 2.6 | 16.4 (6.0-18.0) | 16.7 (14.2-19.1) | 19.8% (15.7-24.6) | 19.0% (14.9-23.4) |
TAPVC repair (280) | 1327 | 4 | 2.6 | 19.2 (6.0-20.0) | 19.1 (17.7-20.6) | 16.4% (14.5-18.5) | 16.4% (14.4-18.4) |
Unifocalization MAPCA(s) (440) | 337 | 4 | 2.6 | 19.4 (6.0-21.0) | 19.2 (16.4-22.0) | 16.6% (13.0-21.0) | 16.4% (12.8-20.4) |
Transplant, lung(s) (1410) | 138 | 4 | 2.6 | 26.8 (13.0-28.0) | 23.3 (18.8-27.7) | 10.1% (6.1-16.3) | 11.9% (7.5-17.1) |
Hypoplastic left heart syndrome biventricular repair (880) | 38 | 4 | 2.7 | 33.1 (9.0-31.0) | 20.7 (12.8-28.5) | 15.8% (7.4-30.4) | 16.2% (7.8-27.5) |
Aortic arch repair + VSD repair (1285) | 353 | 4 | 2.8 | 21.7 (8.0-25.0) | 21.4 (19.0-23.7) | 15.9% (12.4-20.0) | 15.9% (12.3-19.9) |
Aortic dissection repair (1390) | 35 | 4 | 2.9 | 20.9 (5.0-28.5) | 19.9 (14.1-25.5) | 22.9% (12.1-39.0) | 19.5% (10.5-31.2) |
ASD creation/enlargement (60) | 100 | 4 | 2.9 | 24.0 (5.0-26.2) | 21.5 (16.3-26.6) | 18.0% (11.7-26.7) | 18.0% (11.6-25.3) |
Transplant, heart (890) | 821 | 4 | 3 | 23.7 (10.0-27.0) | 23.4 (21.8-25.1) | 16.6% (14.2-19.3) | 16.6% (14.2-19.2) |
Mustard (1140) | 11 | 4 | 3 | 19.6 (6.0-13.5) | 19.5 (11.1-27.7) | 36.4% (15.2-64.6) | 21.5% (8.1-40.7) |
Pulmonary atresia - VSD - MAPCA (pseudotruncus) repair (430) | 98 | 4 | 3.1 | 21.6 (8.0-22.0) | 20.8 (16.2-25.3) | 22.4% (15.3-31.7) | 21.1% (14.1-29.1) |
TOF - absent pulmonary valve repair (400) | 148 | 4 | 3.1 | 29.7 (6.0-27.8) | 24.1 (18.5-29.7) | 16.9% (11.7-23.7) | 17.6% (12.2-23.6) |
Damus–Kaye–Stansel procedure (creation of aortopulmonary anastomosis without arch reconstruction) (1660) | 313 | 4 | 3.3 | 21.3 (7.0-24.0) | 21.2 (18.1-24.3) | 23.3% (19.0-28.3) | 22.9% (18.6-27.6) |
Truncus arteriosus repair (230) | 439 | 4 | 3.4 | 26.1 (9.0-27.0) | 25.1 (22.1-27.9) | 20.0% (16.6-24.0) | 20.2% (16.6-23.9) |
Interrupted aortic arch repair (1320) | 476 | 4 | 3.5 | 28.8 (10.0-35.2) | 27.4 (24.6-30.4) | 18.7% (15.5-22.4) | 19.0% (15.7-22.7) |
Transplant, heart and lung (900) | 10 | 4 | 3.8 | 40.9 (17.0-53.8) | 23.3 (13.7-33.0) | 40.0% (16.8-68.7) | 26.8% (10.0-48.2) |
Arterial switch procedure and VSD repair + aortic arch repair (1125) | 119 | 5 | 4.1 | 23.6 (11.5-29.5) | 23.5 (20.3-26.6) | 32.8% (25.0-41.6) | 31.0% (23.3-39.2) |
Arterial switch procedure + aortic arch repair (1123) | 21 | 5 | 4.3 | 26.0 (10.0-31.0) | 24.4 (17.9-30.7) | 42.9% (24.5-63.5) | 32.7% (18.0-50.3) |
Norwood procedure (870) | 2273 | 5 | 4.9 | 34.6 (14.0-42.0) | 34.1 (32.6-35.7) | 29.6% (27.7-31.5) | 29.7% (27.9-31.6) |
Truncus + IAA repair (3200) | 34 | 5 | 5 | 32.6 (13.0-36.0) | 27.3 (20.3-34.2) | 44.1% (28.9-60.5) | 38.2% (24.8-52.9) |
Complication description (STS code) | No. (%) of events | Mortality N (%) | Rank correlation with “major complication” |
---|---|---|---|
Postoperative acute renal failure requiring temporary or permanent dialysis (220 or 230) | 705 (1.1%) | 396 (56.2%) | 0.59 |
Postoperative neurologic deficit persisting at discharge (320) | 500 (0.8%) | 152 (30.4%) | 0.45 |
Postoperative AV block requiring permanent pacemaker (60) | 593 (0.9%) | 28 (4.7%) | 0.37 |
Postoperative mechanical circulatory support (IABP, VAD, ECMO, or CPS) (40) | 1110 (1.8%) | 617 (55.6%) | 0.54 |
Phrenic nerve injury/paralyzed diaphragm (300) | 578 (0.9%) | 35 (6.1%) | 0.40 |
Unplanned reoperation (20 or 240) | 2942 (4.7%) | 636 (21.6%) | 0.79 |
Major complication (defined as any 1 or more of the above) | 5059 (8.0%) | 1187 (23.5%) | N/A |
The Society of Thoracic Surgeons Congenital Cardiac Surgery Database Data Collection Form. Available at: http://www.sts.org/sites/default/files/documents/pdf/DataCollectionForm250_07102006_Nonannotated.pdf. Accessed December 14, 2011.
Analysis
Creation of Morbidity Scores
Creation of Morbidity Categories
Sensitivity Analyses
Assessment of Statistical Reliability
Results



1 | 2 | 3 | 4 | 5 | |
---|---|---|---|---|---|
No. of procedures | 36 | 43 | 36 | 21 | 4 |
Aggregate average PLOS (d) | 6.3 | 11.3 | 15.2 | 22.3 | 34.0 |
Rate of major complications | 3.2% | 6.5% | 11.9% | 15.2% | 30.0% |
Mortality categories | ||||||
---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | ||
Morbidity categories | 1 | 21 | 13 | 1 | 1 | 0 |
2 | 5 | 26 | 10 | 2 | 0 | |
3 | 0 | 12 | 10 | 13 | 1 | |
4 | 0 | 0 | 3 | 15 | 3 | |
5 | 0 | 0 | 0 | 2 | 2 |
Discussion
- Jacobs J.P.
- Jacobs M.L.
- Mavroudis C.
- Maruszewski B.
- Tchervenkov C.I.
- Lacour-Gayet F.G.
- et al.
Composite Development
Study Limitations
The Society of Thoracic Surgeons Congenital Cardiac Surgery Database Data Collection Form. Available at: http://www.sts.org/sites/default/files/documents/pdf/DataCollectionForm250_07102006_Nonannotated.pdf. Accessed December 14, 2011.
Conclusions
Appendix 1. Statistical appendix
Statistical Model
where denotes the unknown theoretic probability of major complication for the j-th procedure; and denote the unknown mean and variance of PLOS for the j-th procedure; and , denote unknown parameters of the assumed bivariate normal random effects distribution.
Estimation
Composite Morbidity
where
Creation of Categories
where nj is the number of patients in the denominator for the j-th procedure and is the average morbidity of all procedures in the k-th category weighted by their respective sample sizes. If the were known instead of unknown, then the “optimal” cutpoints could (in theory) be determined by enumerating all possible choices for the ck and choosing the one that minimizes the WSS. Because the are unknown, we instead chose cutpoints that minimize the estimated value of WSS (cK). Specifically, we chose cutpoints that minimize the posterior mean
where is the value of on the l-th iteration of the MCMC procedure. An unpublished dynamic programming algorithm was used to determine the set of cutpoints that made this quantity a minimum. The WSS criterion gets smaller as K, the number of categories, increases. The value K = 5 was selected for consistency with the published STS-EACTS mortality categories.
Estimation of Reliability
where
with denoting the value of at the l-th MCMC iteration and denoting the posterior mean of . A 95% CrI for was obtained by calculating the 100th smallest and 100th largest values of across the 4000 MCMC iterations. Analogous calculations were used to estimate reliability for subsets of procedures with at least 10, 30, or 200 cases. An identical approach was also used for estimating the reliability of procedure-specific probability parameters and mean parameters .
Appendix 2. Classification of multiple-procedure operations
Appendix 3. Rescaling of individual outcome measures (average risk of major complications and average postoperative length of stay)
Appendix

References
- Variation in outcomes for benchmark operations: an analysis of The Society of Thoracic Surgeons’ Congenital Heart Surgery Database.Ann Thorac Surg. 2011; 92: 2184-2192
- An empirically based tool for analyzing mortality associated with congenital heart surgery.J Thorac Cardiovasc Surg. 2009; 138: 1139-1153
- Long-term developmental outcome of children with complex congenital heart disease.Clin Perinatol. 2001; 28: 235-247
- Center variation in hospital costs for patients undergoing congenital heart surgery.Circ Cardiovasc Qual Outcomes. 2011; 4: 306-312
- Databases for assessing the outcomes of the treatment of patients with congenital and paediatric cardiac disease–the perspective of cardiac surgery.Cardiol Young. 2008; 18: 101-115
- Methodologic discussions for using and interpreting composite endpoints are limited, but still identify major concerns.J Clin Epidemiol. 2007; 60: 651-657
- What is operative morbidity? Defining complications in a surgical registry database: a report from the STS Congenital Database Task Force and the Joint EACTS-STS Congenital Database Committee.Ann Thorac Surg. 2007; 84: 1416-1421
- The contribution of complications to high resource utilization during congenital heart surgery admissions.Congenit Heart Dis. 2007; 2: 319-326
- Importance of risk stratification models in cardiac surgery.Eur Heart J. 2006; 27: 768-769
- Predictors of long intensive care unit stay following cardiac surgery in children.Eur J Cardiothorac Surg. 2011; 40: 179-184
- Evaluation of a new tool for morbidity assessment in congenital cardiac surgery.Ann Thorac Surg. 2011; 92: 2200-2204
- Complications and risk factors for mortality during congenital heart surgery admissions.Ann Thorac Surg. 2007; 84: 147-155
- Complications, failure to rescue, and mortality with major inpatient surgery in Medicare patients.Ann Surg. 2009; 250: 1029-1034
- Failure-to-rescue: comparing definitions to measure quality of care.Med Care. 2007; 45: 918-925
- The Association of Center Volume with Mortality and Complications in Pediatric Heart Surgery.Pediatrics. 2012; 129: e370-e376
- Consensus-based method for risk adjustment for surgery for congenital heart disease.J Thorac Cardiovasc Surg. 2002; 123: 110-118
- The Aristotle score: a complexity-adjusted method to evaluate surgical results.Eur J Cardiothorac Surg. 2004; 25: 911-924
The Society of Thoracic Surgeons Congenital Cardiac Surgery Database Data Collection Form. Available at: http://www.sts.org/sites/default/files/documents/pdf/DataCollectionForm250_07102006_Nonannotated.pdf. Accessed December 14, 2011.
- WinBUGS—a Bayesian modelling framework: concepts, structure, and extensibility.Stat Comput. 2000; 10: 325-337
Article info
Publication history
Footnotes
Disclosures: Authors have nothing to disclose with regard to commercial support.
Identification
Copyright
User license
Elsevier user license |
Permitted
For non-commercial purposes:
- Read, print & download
- Text & data mine
- Translate the article
Not Permitted
- Reuse portions or extracts from the article in other works
- Redistribute or republish the final article
- Sell or re-use for commercial purposes
Elsevier's open access license policy